摘要
目的分析研究幽门螺杆菌在消化道中的危害与治疗。方法选择2013年6月-2014年6月我院门诊就诊的消化道疾病患者200例为研究对象,进行幽门螺杆菌检查,阳性患者进行奥美拉唑、羟氨苄青霉素/甲硝唑、克拉霉素等治疗,停药1个月后,对治疗效果、幽门螺杆菌的根除效果进行分析。结果本次研究中幽门螺杆菌阳性检出率为慢性浅表性胃炎57.78%(26/45),十二指肠溃疡95.56%(43/45),胃溃疡80.00%(36/45),胃癌60.00%(12/20),复合溃疡95.56%(43/45),幽门螺杆菌阳性总检出率为80.00%。幽门螺杆菌总根除率为95.00%(152/160)。结论在消化道疾病中,幽门螺杆菌感染后消化性溃疡的发病率较高,采用根除治疗,可缓解患者的临床症状,提高生活质量。
Objective To explore the harm and treatment strategies of Helicobacter pylori in the digestive tract. Methods 200 cases of the patients with gastrointestinal disease in our hospital from June 2013 to June 2014 were selected for the study. The patients with positive H. pylori checks received omeprazole, amoxicillin / metronidazole, clarithromycin hormone therapy. One month after discontinuation of treatment, the effect of H. pylori eradication were analyzed. Results H. pylori positive rate of the patients with chronic superficial gastritis, duodenal ulcer, gastric ulcer, stomach cancer and complex ulcers were 57.78%(26/45), 95.56%(43/45), 80.00%(36/45), 60.00%(12/20), 95.56%(43/45), respectively. Helicobacter pyloripositive detection rate was 80.00% of all the patients. Helicobacter pylori eradication rate was 95.00% of all the patients(152/160). Conclusion In the patients with the digestive tract diseases, the incidence of peptic ulcer after Helicobacter pylori infection is high. The eradication therapy is used to relieve symptoms and improve the patients' quality of life.
出处
《中国继续医学教育》
2015年第7期102-102,共1页
China Continuing Medical Education
关键词
幽门螺杆菌
消化道疾病
危害
治疗
Helicobacter pylori
Gastrointestinal diseases
Hazards
Treatment